Skip to main content
OpenTrials
Completed

NCT Number: NCT03240367

Comparison of Stapler Line Bleeding Control Techniquessurgery

Introduction RYGB surgeon; Have become increasingly morbid obesity treatment methods with improvements in minimally invasive surgery. Ensuring patient comfort and early return to life are the criteria that should be given priority in this treatment method.The purpose of this study; Emphasizing that the cautery technique of the stapler line bleeding control methods is as successful as the other methods.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Inonu University

Malatya, 44915, Turkey (Türkiye)

About this study

The question of the availability of cautery in RYGB surgeons

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Morbid obese patients

Exclusion criteria

  • Cirrhotic patients, those under 18 years of age, additional intraabdominal surgeries during LRYGBP and those who had previously undergone obesity surgery (revision surgery)

Treatment and study plan

Coutery

Other

Stapler line bleeding control with coutery

Primary outcomes

  1. 3-item drainage control

    Time frame: 8 months

    Bleeding quantities to be noted

Sponsors and collaborators

Lead sponsor

Ersin Gündoğan

Other

Registry information

Official study title

Comparison of Stapler Line Bleeding Control Techniques in Laparoscopic Gastric Bypass

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Aug 7, 2017
Registry last updated
Aug 7, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.